Medical Oncology Association of
Southern California
P.O. Box 161
Upland, CA 91785
Phone: (909) 985-9061
Fax: (909) 985-8581
email: moasc@moasc.org
|
|
|
MOASC would like to recognize and thank the following sponsors for their continued support of MOASC:
|
|
|
|
Posted July 12, 2005 |
|
MOASC with support from Astra Zeneca is pleased to present the following educational web seminars highlighting
the Astra Zeneca Cancer Support Network & Medicare Reform Updates
 July 19, 2005 - 12-1 PM
July 20, 2005 - 12-1 PM
July 21, 2005 - 12-1 PM
July 26, 2005 - 12-1 PM
July 27, 2005 - 12-1 PM
July 28, 2005 - 12-1 PM
Join Us for A Web Ex Conference. These live Web Ex sessions will provide participants
with an overview of the support services
available through the AstraZeneca Cancer
Support Network, as well as a Medicare Reform
Update.
The Medicare-related discussion will
include changes to the reimbursement
methodology for physician-administered drugs
and administration services, the Competitive
Acquisition Program (CAP), the Medicare
Replacement Drug Demonstration (MRDD)
project, and the upcoming Medicare Part D
prescription drug benefit. There will be a question
and answer session at the end of each program.
Download the brochure and registration form here>>. Please fax the attached registration form to 888-657-8839 or email to registration@aristamktg.com and reference the A485 series.
If you have any questions, please contact Astrazencea at 888-498-7425 or the MOASC office at (909) 985-9061.
“ONS Chemotherapy & Biotherapy Course”
October 7-8, 2005,
Pasadena, CA. This program will offer 16.2 continuing education hours and is accredited by ONS. Please note: If you have attended this class before, you can renew your certificate online at www.ons.org. You do not need to attend again. If you have any questions, please contact the MOASC office at (909) 985-9061.
Invitations will be mailed out in July 2005.
|
|
Report Finds Participants in Pay-For-Performance Program Show Improvements
About 225 medical groups participating in Integrated Healthcare
Association's pay-for-performance program in 2004 made progress in 14
clinical quality standards, including implementation of health information
technology, according to a report IHA released last week, the San Francisco
Business Times reports. Source: California Healthline.
|
|
MM3819 - (CR3819)
The Medicare Claims Processing Manual and claims processing systems are being
revised to include a new Place of Service (POS) code for pharmacy of 01.
MM3888 - (CR3888)
CMS has revised the article on the annual update of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) . This update will apply for claims with service dates on or after October 1, 2005. (CR 3888)
MM3742 - (CR3742)
CMS has revised the article on the National Coverage Determination ( NCD ) covering the off-label use of certain colorectal anti-cancer drugs in identified clinical trials of colorectal cancer and other cancer types. (CR 3742)
SE0540
CMS has released a national educational guide on Remittance Advice (RA) Notices.
Local Coverage Determinations
Article about updates to the Local Coverage Determinations (LCDs)
|
|
Quarterly Provider Update
CMS publishes The Quarterly Provider Update on the first business day of each quarter. It is a listing of all non-regulatory changes to Medicare including Program Memoranda, manual changes, and any other instructions that could affect providers.
The purpose of the Quarterly Provider Update is to:
· Inform providers about new developments in the Medicare program;
· Assist providers in understanding CMS programs and complying with Medicare regulations and instructions;
· Ensure that providers have time to react and prepare for new requirements;
· Announce new or changing Medicare requirements on a predictable schedule; and
· Communicate the specific days that CMS business will be published in the Federal Register.
The Quarterly Provider Update can be accessed at http://www.cms.gov/providerupdate.
We encourage you to bookmark this website and visit it often for this valuable information.
|
|
|
|
|
|
